List view / Grid view
25 November 2016 | By Niamh Louise Marriott, Digital Content Producer
J is for Joint Pain - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest in this chronic joint pain research...
24 November 2016 | By Niamh Louise Marriott, Digital Content Producer
I is for Immuno-oncology - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest in this cancer research...
23 November 2016 | By Niamh Louise Marriott, Digital Content Producer
H is for Hepatitis C - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest in Hep C research...
22 November 2016 | By Monica McDonnell, Informatica
Informatica's Monica McDonnell gives the lowdown on the Identification of Medicinal Products new regulations and how to manage big data all across Europe...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
G is for Gene - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest gene research...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
F is for Funding - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest grants and funds...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
E is for Epilepsy - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research on Epilepsy...
17 November 2016 | By Leif Poulsen, Global technology Partner, NNE Pharmaplan
European Pharmaceutical Review brought you all the latest research and development live from the conference. Now read NNE Pharmaplan's Leif Poulsen's round up of the event…
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
D is for Dementia - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research on Dementia...
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
We caught up with Bonesupport's CEO Richard Davies to find out how they're using artificial bone grafts to help sufferers of chronic osteomyelitis...
16 November 2016 | By Niamh Louise Marriott, Digital Content Producer
C is for Cancer Drugs Fund - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest on the Cancer Drugs Fund
15 November 2016 | By Niamh Louise Marriott, Digital Content Producer
B is for Biosimilar - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research on the subject of biosimilars.
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A is for Antibiotics - the first instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research on the subject of antibiotics.
14 November 2016 | By Norma McGough, Director of Policy, Research & Campaigns, Coeliac UK
Coeliac UK’s Director of Policy, Research & Campaigns, Norma McGough, welcomes NICE’s new quality standards on coeliac disease, which she believes will bring clarity and improvement to diagnosis screening and better access to long term treatment…
7 November 2016 | By Jurgi Camblong, CEO and co-founder of Sophia Genetics
Sophia Genetics' CEO Jurgi Camblong says genomic data can now diagnose and tailor individual treatments but how do we democratise Data-Driven Medicine?
